NCT00422110View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures

PHASE2/PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 2008

Conditions
Epilepsies, Partial
Interventions
DRUG

Seletracetam

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY